Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX), CEN Biotech, today announced that it has selected Michael K. Clark as Vice Chairman of its Board of Directors effective immediately.
"Michael has played a vital role in our company's strategic rollout, and his investment knowledge, business acumen and strong leadership is the underpinning for our future growth," commented Bill Chaaban, President & CEO. "As our company continues to define itself as a market leader, it is important to have a person of Michael's caliber and vision serve in the Vice Chairman role." Clark added, "I am excited to serve as Creative Edge Nutrition's new Vice Chairman, and I am honored to have been chosen among the boards deep talent bench."
Mr. Clark was Chief Executive Office of Clark Dodge Holdings, a multi-faceted financial holding company providing services that include investment banking for private equity, venture capital and late stage financing for public and private companies. He joins CEN Biotech with over 25 years of experience in the global securities industry having led the growth of several international servicing and financing companies including Fidelity and JP Morgan.
Mr. Clark has also served as Vice Chairman of Standard Charter Bank focusing on the Institutional market place. Prior to joining CEN Biotech, Mr. Clark held several senior positions including President of Fidelity Institutional Investments. He also served on their executive committee. Mr. Clark spent 15 years at JPMorgan where he ran the Division known as Worldwide Securities Services that service 22 Trillion dollars of investments More recently, Mr. Clark was Chief Executive Officer at Butterfield Fulcrum Group, a Hedge fund servicing company, from July 2010 to December 2011. Mr. Clark also served as Chairman of World Surveillance Group Inc. and Global Telesat Corp., from June 2010 until April 2012. He holds a double B.S. from SUNY Maritime College, an Executive M.B.A. from New York University, and an MS from USC in Quantitative Analysis and Statistics.
About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) (PINKSHEETS: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.
About Creative Edge Nutrition, Inc.
Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. http://www.cenergynutrition.com and https://www.facebook.com/CenergyNutrition
FOR INVESTOR RELATIONS
SOURCE: Creative Edge Nutrition, Inc.